Dompé Farmaceutici S.p.A
57
2
2
37
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
24.6%
14 terminated/withdrawn out of 57 trials
72.5%
-14.0% vs industry average
21%
12 trials in Phase 3/4
111%
41 of 37 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (57)
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Role: collaborator
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
Role: lead
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Role: lead
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Role: lead
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
Role: lead
Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia
Role: lead
A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.
Role: lead
QST for Corneal Nerve Function
Role: collaborator
A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function
Role: lead
DEFENDO Long Term Follow-up Study in Stage 1 NK Patients
Role: lead
Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease
Role: lead
Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye
Role: lead
Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis
Role: lead
Add-on Reparixin in Adult Patients With ARDS
Role: lead
A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.
Role: lead
Corneal Nerves After Treatment With Cenegermin
Role: collaborator
Tolerability, Safety and Efficacy of Lubricin vs Sodium Hyaluronate Eye Drops in Subjects With Moderate Dry Eye
Role: lead
Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.
Role: lead
Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Liver Transplantation
Role: lead
A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Males
Role: lead